How A First-Time CEO Transformed Retrophin Into Travere Therapeutics
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
“ARE YOU KIDDING ME?”
That was the first thought Eric Dube, Ph.D., had when an executive recruiter pitched to him a CEO opportunity at Retrophin back in 2018. After all, Dube knew of the San Diego-based biopharma’s infamous past with its cofounder and one-time CEO, Martin Shkreli, so his initial reaction was to be dubious.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader